TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling

Immunity

Volumn 21, Issue 4, 2004, Pages 491-501

  Becker, Christoph ^a   Fantini, Massimo C ^a   Schramm, Christoph ^a   Lehr, Hans A ^a   Wirtz, Stefan ^a   Nikolaev, Alexei ^a   Burg, Jürgen ^a   Strand, Susanne ^a   Kiesslich, Ralf ^a   Huber, Samuel ^a   Ito, Hiroaki ^b   Nishimoto, Norihiro ^b   Yoshizaki, Kazuyuki ^b   Kishimoto, Tadamitsu ^b   Galle, Peter R ^a   Blessing, Manfred ^c   Rose John, Stefan ^d   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PREVENTION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; GASTROINTESTINAL ENDOSCOPY; GENE OVEREXPRESSION; GROWTH REGULATION; HISTOPATHOLOGY; MEMBRANE BINDING; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANS ISOMER; TRANSGENIC MOUSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY;

ANIMALS; BLOTTING, WESTERN; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENDOSCOPY, DIGESTIVE SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 5644252874     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.07.020     Document Type: Article

References (32)

1. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 19:2000;2607-2611
2. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., Schütz M., Bartsch B., Holtmann M., Becker C., et al. Blockade of IL-6 trans-signaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation. Evidence in Crohn's disease and experimental colitis in vivo Nat. Med. 6:2000;583-588
3. Becker C., Wirtz S., Blessing M., Pirhonen J., Strand D., Bechthold O., Frick J., Galle P.R., Autenrieth I., Neurath M.F. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112:2003;693-706
4. Borrell-Pages M., Rojo F., Albanell J., Baselga J., Arribas J. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J. 22:2003;1114-1124
5. Chen Q., Wang W.C., Bruce R., Li H., Schleider D.M., Mulbury M.J., Bain M.D., Wallace P.K., Baumann H., Evans S.S. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity. 20:2004;59-70
6. Chung Y.C., Chang Y.F. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg. Oncol. 83:2003;222-226
7. Coffey R.J., Shipley G.D., Moses H.L. Production of transforming growth factors by human colon cancer lines. Cancer Res. 46:1986;1164-1169
8. Dowdall J.F., Winter D.C., Andrews E., Laug W.E., Wang J.H., Redmond H.P. Soluble interleukin 6 receptor (sIL-6R) mediates colonic tumor cell adherence to the vascular endothelium. a mechanism for metastatic initiation? J. Surg. Res. 107:2002;1-6
9. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P., Kallen K.J., Wollmer A., Grotzinger J., Rose-John S. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat. Biotechnol. 15:1997;142-145
10. Funada Y., Noguchi T., Kikuchi R., Takeno S., Uchida Y., Gabbert H.E. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol. Rep. 10:2003;309-313
11. Galizia G., Orditura M., Romano C., Lieto E., Castellano P., Pelosio L., Imperatore V., Catalano G., Pignatelli C., Vita F.D. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin. Immunol. 102:2002;169-178
12. Glimcher L.H., Murphy K.M. Lineage commitment in the immune system. the T helper lymphocyte grows up Genes Dev. 14:2000;1693-1711
13. Grady W.M., Myeroff L.L., Swinler S.E., Rajput A., Thiagalingam S., Lutterbaugh J.D., Neumann A., Brattain M.G., Chang J., Kim S.J., et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59:1999;320-324
14. Heath V.L., Murphy E.E., Crain C., Tomlinson M.G., O'Garra A. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30:2000;2639-2649
15. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G.M., Topley N., Jones S.A. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 14:2001;705-714
16. Jones S.A., Horiuchi S., Topley N., Yamamoto N., Fuller G.M. The soluble interleukin 6 receptor. mechanisms of production and implications in disease FASEB J. 15:2001;43-58
17. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:2002;933-944
18. Naka T., Nishimoto N., Kishimoto T. The paradigm of IL-6. from basic science to medicine Arthritis Res. Suppl. 4:2002;S233-S242
19. Neurath M.F., Finotto S., Glimcher L.H. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:2002;567-573
20. Okayasu I., Ohkusa T., Kajiura K., Kanno J., Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 39:1996;87-92
21. Rengarajan J., Szabo S.J. Transcriptional regulation of Th1/Th2 polarization. Immunol. Today. 21:2000;479-483
22. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315-325
23. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors. generation and biological function Biochem. J. 300:1994;281-290
24. Rose-John S., Neurath M.F. IL-6 trans-signaling. the heat is on Immunity. 20:2004;2-4
25. Schneider M.R., Hoeflich A., Fischer J.R., Wolf E., Sordat B., Lahm H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 151:2000;31-38
26. Schramm C., Protschka M., Kohler H.H., Podlech J., Reddehase M.J., Schirmacher P., Galle P.R., Lohse A.W., Blessing M. Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 284:2003;525-535
27. Seder R.A., Marth T., Sieve M.C., Strober W., Letterio J.J., Roberts A.B., Kelsall B. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells. IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production J. Immunol. 160:1998;5719-5728
28. Sunnarborg S.W., Hinkle C.L., Stevenson M., Russell W.E., Raska C.S., Peschon J.J., Castner B.J., Gerhart M.J., Paxton R.J., Black R.A., Lee D.C. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277:2002;12838-12845
29. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori M. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94:2003;965-973
30. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B., Waring P., Clay F.J., Malki S., Alderman B.M., Grail D., Hollande F., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8:2002;1089-1097
31. Weir H.K., Thun M.J., Hankey B.F., Ries L.A., Howe H.L., Wingo P.A., Jemal A., Ward E., Anderson R.N., Edwards B.K. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl. Cancer Inst. 95:2003;1276-1299
32. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18:1999;1280-1291